Welcome to Drug and Alcohol Treatment
| ||
Alcohol Treatment Fda Article
This is a selection made from among articles on Alcohol Treatment Fda. For a permanent link to this article, or to bookmark it for future reading, click here.
from:
Which Drug Rehab Or Alcohol Treatment Level Of Care Is Best?
By Bill Urell
Before we look for a drug rehab or alcohol treatment program, we have to look at the level of care needed and assess the severity of the problem. Just as there are various levels of use of mood altering drugs, there are various levels of treatment available. Within each clarification there are variances of cost, and length of treatment. Here are some levels of care and examples of what may be appropriate for a situation.
Brief Therapy/Intervention - This is usually a very short duration program, but can be very effective. Perhaps a person who really is not involved with alcohol over does it one time on a birthday or New Years and is caught on their first DUI. They may be mandated to attend alcohol classes where education is provided for a few weeks.
Detoxification - The idea that detox is drug treatment is a common misconception. The purpose of a 'Detox' is to safely monitor and de-escalate an incident of intoxification. Generally, as soon as you are medically stable (which is not recovery treatment) you are dismissed from the hospital or facility. Supervised detox is recommended for long term alcohol or benzodiazepine (Xanax, Ambien etc) users as the risk of seizures exists. This may be a required first step before entering treatment.
Outpatient Program - This is non-residential treatment usually consisting of attending a therapy group and/or individual counseling once or twice/week. This may be appropriate for a person whose use is starting to cause problems, but is not yet dependent
Intensive Outpatient Program - This is non residential but generally consists of 16-20 hours of group and individual therapy per week. Insurance is more likely to cover this form of treatment rather than inpatient treatment. This is less costly than residential, but is appropriate for a person with full dependency. Outpatient programs may be used as a 'step down' after completing residential treatment
Inpatient Treatment - This is your classic 'drug rehab'. It is residential and the programs generally consist of a full day of activities and may last from 4 weeks to a year. It is the most intense form of treatment and these facilities are usually equipped to handle additional global problems associated with addiction such as mental health, physical, emotional and spiritual areas.
I am definitely biased. That being said, I would recommend inpatient treatment for anyone with addiction or chemical dependency. The primary advantage is that the evidence is clear that a longer exposure to treatment increases the probability of a good outcome. One disadvantage is that inpatient treatment can be costly and insurance generally does not cover it.
The important thing is to get a proper professional assessment so you can be matched with an appropriate level of care.
Tell your story! Pick up addiction recovery tips and tricks to enhance your life free of addictions. Join our growing community. The author, Bill Urell MA.CAAP-II, is an addictions therapist at a leading residential treatment center. He teaches healthy life styles and life skills. Visit http://www.AddictionRecoveryBasics.com/
Article Source: http://EzineArticles.com/?expert=Bill_Urell
http://EzineArticles.com/?Which-Drug-Rehab-Or-Alcohol-Treatment-Level-Of-Care-Is-Best?&id=475685
Alcohol Treatment Fda Specific links
Alcohol Treatment Fda News
A hope for release from demon alcohol - Sarasota Herald-Tribune
 Sarasota Herald-Tribune | A hope for release from demon alcohol Sarasota Herald-Tribune (The FDA approved acamprosate, marketed as Campral by Forest Laboratories, in 2004. Naltrexone, now available as a generic, was first approved as an oral treatment for alcohol abuse in 1994 and, in 2006, became available as a monthly injection known as ... |
FDA Approves Levemir® for Expanded Use in Children Two to Five Years of Age ... - MarketWatch (press release)
FDA Approves Levemir® for Expanded Use in Children Two to Five Years of Age ... MarketWatch (press release) The FDA approval now makes Levemir® the first and only basal insulin analog for use in this young patient group. "Our biggest challenges and top priorities when treating some of the youngest children with type 1 diabetes are safety and reducing the ... |
Smoking drug effective in treating drinking - The Aggie
Smoking drug effective in treating drinking The Aggie Varenicline, commonly known by the brand name Chantix, has been FDA-approved since 2006 for helping people to stop smoking, but only recently did the researchers theorize that the drug could reduce alcohol consumption and began testing the drug on rats ... |
Vivus Announces FDA Approval Of STENDRA(TM) (avanafil) Tablets For The ... - MarketWatch (press release)
 Bloomberg | Vivus Announces FDA Approval Of STENDRA(TM) (avanafil) Tablets For The ... MarketWatch (press release) MOUNTAIN VIEW, Calif., April 27, 2012 /PRNewswire via COMTEX/ -- VIVUS, Inc. (NASDAQ:VVUS) today announced that the US Food and Drug Administration (FDA) has approved STENDRA (avanafil) tablets for the treatment of erectile dysfunction (ED), ... FDA Gives Approval Of STENDRA™ (avanafil) Tablets For The Treatment Of ... FDA approves new drug for erectile dysfunction |
FDA report on Gilead's Quad focuses on kidney safety - Reuters
 CBS News | FDA report on Gilead's Quad focuses on kidney safety Reuters The regulators said the four-drugs-in-one treatment has a generally acceptable safety profile. But they found evidence of disproportionate numbers of adverse renal events among test subjects that may need to be monitored. They also cautioned that ... FDA focuses on kidney safety of Gilead's HIV pill |
Raging epidemic - Wayne Post
Raging epidemic Wayne Post Pictured, left to right, Glen Johnson, environmental prevention specialist at the Council on Alcoholism and Addictions of the Finger Lakes; Wayne County Sheriff Barry Virts; Bill Fox, director of treatment services at Finger Lakes Addictions Counseling ... |
Tailored treatments bring decline in deaths - Peoria Journal Star
Tailored treatments bring decline in deaths Peoria Journal Star Kesslering encourages women to discuss alcohol use, family history and other risk factors with their physicians. At the end of 2011, the FDA revoked the approval of Avastin, a popular breast cancer drug, Rowden said. "Some people respond well to ... |
Galectin Therapeutics Looks to Pioneer New Industry in Medicine - Equities.com
Galectin Therapeutics Looks to Pioneer New Industry in Medicine Equities.com Yet, aside from transplant surgery, there is still no viable long-term solution to treat liver damage and failure caused by diseases such as various forms of hepatitis, results of alcohol abuse, and fatty liver disease. These conditions lead to liver ... |
Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide ... - MarketWatch (press release)
Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide ... MarketWatch (press release) The study found, among patients who had at least a one-point reduction in pain intensity during three weeks of treatment with tapentadol ER, those who continued on an optimized dose of tapentadol ER (100-250 mg twice daily) for an additional 12 weeks ... |
Facebook and physicians: Not good medicine - Computerworld New Zealand
Facebook and physicians: Not good medicine Computerworld New Zealand Many have switched to private professional networking sites, which allow them to discuss medical cases in professional forums, seek out colleagues for remote consultations and read up on the latest treatments and outcomes. In a 2009 survey of deans at ... |